The Indian Council for Medical Research (ICMR) tie-up with Bharat Biotech to develop indigenous COVID-19 vaccine. The vaccine is to be developed using virus strains that have been isolated from COVD-19 patients at ICMR’s National Institute of Virology (NIV), Pune.
ICMR has shared one of the 11 virus strains that it managed to culture with Bharat Biotech. The industry partnership is to develop the vaccine candidate and ICMR has transferred the technology to them One of the strains has now been successfully transferred from NIV to Bharat Biotech International Ltd. (BBIL) in Hyderabad as part of the partnership. ICMR-NIV will provide continuous support to BBIL for vaccine development.
Important takeaways for all competitive exams
India has produced several memorable batting performances in International ODI cricket and remains one of…
The Comprehensive Economic and Trade Agreement (CETA) and the Agreement on Social Security Contributions which…
The FIFA World Cup 2026 has officially started form 11th June with exciting opening-round fixtures…
Argentine superstar Lionel Messi has became the first player ever to appear in six FIFA…
The Maharashtra Cabinet has approved the establishment of the High-Energy Medical Cyclotron Project (HEMCP) in…
India and Japan have strengthened the bilateral climate cooperation by adopting the Rules of Implementation…